RE-BVS – Piemonte Repository

Sfoglia per AUTORE
RUSSO D
Collezione ASL Vercelli

Items : 4

Late Breaking Abstract - New imaging approach to evaluate the in vivo administration of nanostructured mycophenolic acid in a preclinical model of SSC-ILD in European Respiratory Journal

2024
ASL Vercelli

Chiazza F; Mantovani E; Marengo A; Russo D; Ragnoli B; Malerba M;

Effectiveness of Switch to Erythropoiesis-Stimulating Agent (ESA) Biosimilars versus Maintenance of ESA Originators in the Real-Life Setting: Matched-Control Study in Hemodialysis Patients. in Clinical drug investigation / Clin Drug Investig. 2017 Oct;37(10):965-973. doi: 10.1007/s40261-017-0562-8.

2017
ASL Vercelli

Minutolo R; Bolasco P; Chiodini P; Sposini S; Borzumati M; Abaterusso C; Mele AA; Santoro D; Canale V; Santoboni A; Filiberti O; Fiorini F; Mura C; Imperiali P; Borrelli S; Russo L; De Nicola L; Russo D;

Dosing Penalty of Erythropoiesis-Stimulating Agents After Switching From Originator to Biosimilar Preparations in Stable Hemodialysis Patients. in American journal of kidney diseases : the official journal of the National Kidney Foundation / Am J Kidney Dis. 2016 Jul;68(1):170-2. doi: 10.1053/j.ajkd.2016.01.011. Epub 2016 Feb 13.

2016
ASL Vercelli

Minutolo R; Borzumati M; Sposini S; Abaterusso C; Carraro G; Santoboni A; Mura C; Filiberti O; Santoro D; Musacchio R; Imperiali P; Fiorini F; De Nicola L; Russo D;

Azacitidine for the treatment of lower risk myelodysplastic syndromes: A retrospective study of 74 patients enrolled in an Italian named patient program in Cancer

2010
ASL Vercelli

Musto P; Maurillo L; Spagnoli A; Gozzini A; Rivellini F; Lunghi M; Villani O; Aloe-Spiriti MA; Venditti A; Santini V; Leone G; Voso MT; D'Arco AM; Tatarelli C; Ferrero D; Gaidano G; Palumbo G; Di Raimondo F; Oliva E; Sanpaolo G; Tonso A; Santagostino A; Filardi N; Pollio B; Candoni A; Fili C; Russo D; Orciuolo E; Petrini M; et alii...